Related Experiment Video
Updated: Aug 23, 2025

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4
Yan Mo1,2,3,4, Shoufu Duan1,2,3,4, Xu Zhang1,2,3,4
1Institute for Cancer Genetics, Columbia University Irving Medical Center, New York, New York.
Abstract:
Patients with diffuse midline gliomas that are H3K27 altered (DMG) display a dismal prognosis. However, the molecular mechanisms underlying DMG tumorigenesis remain poorly defined. Here we show that SMARCA4, the catalytic subunit of the mammalian SWI/SNF chromatin remodeling complex, is essential for the proliferation, migration, and invasion of DMG cells and tumor growth in patient-derived DMG xenograft models. SMARCA4 colocalizes with SOX10 at gene regulatory elements to control the expression of genes involved in cell growth and the extracellular matrix (ECM). Moreover, SMARCA4 chromatin binding is reduced upon depletion of SOX10 or H3.3K27M, a mutation occurring in about 60% DMG tumors. Furthermore, the SMARCA4 occupancy at enhancers marked by both SOX10 and H3K27 acetylation is reduced the most upon depleting the H3.3K27M mutation. Taken together, our results support a model in which epigenome reprogramming by H3.3K27M creates a dependence on SMARCA4-mediated chromatin remodeling to drive gene expression and the pathogenesis of H3.3K27M DMG.
Significance:
DMG is a deadly pediatric glioma currently without effective treatments. We discovered that the chromatin remodeler SMARCA4 is essential for the proliferation of DMG with H3K27M mutation in vitro and in vivo, identifying a potentially novel therapeutic approach to this disease. See related commentary by Beytagh and Weiss, p. 2730. See related article by Panditharatna et al., p. 2880. This article is highlighted in the In This Issue feature, p. 2711.
Insights
Diffuse midline gliomas (DMG) with H3K27 alterations are aggressive. The study reveals SMARCA4 is crucial for DMG cell growth and tumor progression, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Diffuse midline gliomas (DMG) with H3K27 alterations present a poor prognosis and undefined molecular drivers.
- Current treatments for DMG are ineffective, highlighting the need for novel therapeutic strategies.
Discussion:
- SMARCA4, a key component of the SWI/SNF chromatin remodeling complex, is demonstrated to be essential for DMG cell proliferation, migration, and invasion.
- SMARCA4 interacts with SOX10 at gene regulatory elements, influencing the expression of genes critical for cell growth and extracellular matrix remodeling.
- The binding of SMARCA4 to chromatin is dependent on SOX10 and the H3K27M mutation, with significant reduction observed upon H3K27M depletion.
Key Insights:
- Epigenetic reprogramming by the H3K27M mutation creates a dependency on SMARCA4-mediated chromatin remodeling in DMG pathogenesis.
- SMARCA4 plays a vital role in driving gene expression essential for the growth and progression of H3K27M-mutant DMG.
- This research identifies SMARCA4 as a potential therapeutic target for H3K27M-mutant diffuse midline gliomas.
Outlook:
- Targeting SMARCA4 could offer a novel therapeutic avenue for patients with deadly pediatric gliomas.
- Further investigation into the precise mechanisms of SMARCA4 regulation in DMG is warranted.
- Understanding the interplay between H3K27M, SOX10, and SMARCA4 may lead to more effective treatment strategies for diffuse midline gliomas.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Induced Pluripotent Stem Cells
Somatic...
Somatic to iPS Cell Reprogramming
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Abnormal Proliferation

